The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1353
December 13, 2010
View Complete Issue         Table of Contents 2019 
Clindamycin-Tretinoin (Veltin Gel) for Acne
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Clindamycin-Tretinoin (Veltin Gel) for Acne
December 13, 2010 (Issue: 1353)
Veltin Gel (Stiefel), a fixed-dose combination of the antibiotic clindamycin phosphate 1.2% and the retinoid tretinoin 0.025%, has been approved by the FDA for topical treatment of acne vulgaris in patients ≥12 years old. Another product...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Clindamycin-Tretinoin (Veltin Gel) for Acne
Article code: 1353d
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.